Patents by Inventor Ritchie Shoemaker

Ritchie Shoemaker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9770170
    Abstract: The present invention relates generally to the diagnosis, treatment, and monitoring of Chronic Inflammatory Response Syndrome (CIRS), kits for use in the methods, and pharmaceutical compositions for use in the methods of treatment. The invention specifically relates to the diagnosis, treatment and monitoring of CIRS through a comprehensive approach comprising an assessment of a subject for case definition parameters and a proteogenomic analysis. The proteogenomic analysis for the diagnosis, treatment, and monitoring of CIRS is based on identifying proteins and/or genes that are differentially expressed in subjects suffering from CIRS compared to healthy subjects.
    Type: Grant
    Filed: August 7, 2013
    Date of Patent: September 26, 2017
    Inventors: Ritchie Shoemaker, Jimmy Ryan
  • Publication number: 20140046143
    Abstract: The present invention relates generally to the diagnosis, treatment, and monitoring of Chronic Inflammatory Response Syndrome (CIRS), kits for use in the methods, and pharmaceutical compositions for use in the methods of treatment. The invention specifically relates to the diagnosis, treatment and monitoring of CIRS through a comprehensive approach comprising an assessment of a subject for case definition parameters and a proteogenomic analysis. The proteogenomic analysis for the diagnosis, treatment, and monitoring of CIRS is based on identifying proteins and/or genes that are differentially expressed in subjects suffering from CIRS compared to healthy subjects.
    Type: Application
    Filed: August 7, 2013
    Publication date: February 13, 2014
    Inventors: Ritchie SHOEMAKER, Jimmy Ryan
  • Publication number: 20030219400
    Abstract: The present invention discloses methods of treating or inhibiting one or more of sick building syndrome (SBS), post-Lyme Disease Syndrome (PLDS), and chronic fatigue syndrome (CFS) by administering to a patient in need thereof an amount effective of cholestyramine and/or &agr;-melanocyte stimulating hormone to treat or inhibit one or more of these syndromes.
    Type: Application
    Filed: February 10, 2003
    Publication date: November 27, 2003
    Inventors: Ritchie Shoemaker, H. Kenneth Hudnell